Páncreas artificial

La regulación automática y semiautomática de la glucemia en pacientes con Diabetes mellitus Tipo 1 es un problema de control muy desafiante. La principal desventaja de las terapias de lazo abierto y de lazo cerrado es el exceso de insulina provisto después de las comidas, el cual en muchos casos produce severos eventos de hipoglucemia. La variabilidad intra-paciente, retardos y falta de mediciones precisas del nivel de glucosa en sangre imponen fuertes limitaciones a la performance alcanzable. Desarrollamos algoritmos de control para reducir los eventos de hipoglucemia sin incrementar el riesgo de hiperglucemia.


Publicaciones

Theses

Rosales N.  2020.  Modelado y simulación de tecnologías para el tratamiento de la diabetes.

Patents

De Battista H, Garelli F, León F, Vehí J.  Submitted.  Method and software for the determination and time profile of an insulin dosis.

Book Chapters

Colmegna P, Garelli F, De Battista H, Bianchi FD, Sánchez-Peña R.  2019.  The ARG algorithm: clinical trials in Argentina. The Artificial Pancreas: current situation and future directions. :79-104.

Journal Articles

Fushimi E, De Battista H, Garelli F.  2022.  A Dual-Hormone Multicontroller for Artificial Pancreas Systems. IEEE Journal of Biomedical and Health Informatics. :1-8.
Rosales N, De Battista H, Garelli F.  2022.  Hypoglycemia prevention: PID-type controller adaptation for glucose rate limiting in Artificial Pancreas System. Biomedical Signal Processing and Control. 71:103106.
Rodríguez-Sarmiento DL, León-Vargas F, Garelli F.  2022.  Practical constraint definition in safety schemes for artificial pancreas systems. The International Journal of Artificial Organs. 45:535-542.
Garelli F, Fushimi E, Rosales N, Arambarri D, Serafini MCecilia, De Battista H, Grosembacher L, Sánchez-Peña RSalvador.  2022.  Control no-híbrido de glucemia ensayado en pacientes ambulatorios con Diabetes Tipo 1. Revista Iberoamericana de Automática e Informática industrial.
Garelli F, Fushimi E, Rosales N, Arambarri D, Mendoza L, Serafini MCecilia, Moscoso-Vásquez M, Stasi M, Duette P, García-Arabehety J et al..  2022.  First Outpatient Clinical Trial of a Full Closed-Loop Artificial Pancreas System in South America. Journal of Diabetes Science and Technology. :19322968221096162.
Moscoso-Vásquez M, Colmegna P, Rosales N, Garelli F, Sánchez-Peña R.  2020.  Control-Oriented Model with Intra-Patient Variations for an Artificial Pancreas. IEEE Journal of Biomedical and Health Informatics. :1-1.
Fushimi E, Serafini MCecilia, De Battista H, Garelli F.  2020.  Automatic glycemic regulation for the pediatric population based on switched control and time-varying IOB constraints: an in silico study. Medical & Biological Engineering & Computing.
Garelli F, Rosales N, Fushimi E, Arambarri D, Mendoza L, De Battista H, Sánchez-Peña R, Arabehety JGarcía, Distefano S, Barcala C et al..  2020.  Remote Glucose Monitoring Platform for Multiple Simultaneous Patients at Coronavirus Disease 2019 Intensive Care Units: Case Report Including Adults and Children. Diabetes Technology & Therapeutics.
García-Jaramillo M, León-Vargas F, Rosales N, Molano A, Garelli F.  2019.  Interval Simulator of the Glucose-Insulin System. Applied Computer Sciences in Engineering.
Fushimi E, Colmegna P, De Battista H, Garelli F, Sánchez-Peña R.  2019.  Artificial Pancreas: Evaluating the ARG Algorithm Without Meal Announcement. Journal of Diabetes Science and Technology. :1932296819864585.
Sánchez-Peña R, Colmegna P, Garelli F, De Battista H, García-Violini D, Moscoso-Vásquez M, Rosales N, Fushimi E, Campos-Náñez E, Breton M et al..  2018.  Artificial Pancreas: Clinical Study in Latin America Without Premeal Insulin Boluses. Journal of Diabetes Science and Technology. 12(5):914-925.
Rosales N, De Battista H, Vehí J, Garelli F.  2018.  Open-loop glucose control: Automatic IOB-based Super-Bolus feature for commercial insulin pumps. Computer Methods and Programs in Biomedicine. 159:145-158.
Colmegna P, Garelli F, De Battista H, Sánchez-Peña R.  2018.  Automatic regulatory control in type 1 diabetes without carbohydrate counting. Control Engineering Practice. 74:22-32.
Fushimi E, Rosales N, De Battista H, Garelli F.  2018.  Artificial pancreas clinical trials: Moving towards closed-loop control using insulin-on-board constraints. Biomedical Signal Processing and Control. 45:1-9.
Sánchez-Peña R, Colmegna P, Grosembacher L., Breton M., De Battista H, Garelli F, Belloso W.H, Campos-Nánez E., Simonovich V., Beruto V. et al..  2017.  Artificial Pancreas: First Clinical Trials in Argentina. IFAC-PapersOnLine. 50:7731-7736.
León-Vargas F, Garelli F, De Battista H, Vehí J.  2015.  Postprandial response improvement via safety layer in closed-loop blood glucose controllers. Biomedical Signal Processing and Control. 16:80-87.
Revert A, Garelli F, Picó J, De Battista H, Rossetti P, Vehí J, Bondia J.  2015.  Safety auxiliary feedback element for the artificial pancreas in type 1 diabetes. Diabetes Technology and Therapeutics. 17:S35-S36.
Revert A, Garelli F, Picó J, De Battista H, Rossetti P, Vehí J, Bondia J.  2013.  Safety Auxiliary Feedback Element for the Artificial Pancreas in Type 1 Diabetes. Biomedical Engineering, IEEE Transactions on. 60:2113-2122.
León-Vargas F, Garelli F, De Battista H, Vehí J.  2013.  Postprandial blood glucose control using a hybrid adaptive PD controller with insulin-on-board limitation. Biomedical Signal Processing and Control. 8:724-732.